MIC
IDXX icon

Means Investment Company’s Idexx Laboratories IDXX Stock Holding History

Means Investment Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
1,816
-27
-1% -$17.3K 0.09% 84
2025
Q4 		$1.25M Hold
1,843
– – 0.11% 78
2025
Q3 		$1.18M Sell
1,843
-237
-11% -$144K 0.1% 82
2025
Q2 		$1.12M Sell
2,080
-41
-2% -$19.6K 0.11% 86
2025
Q1 		$891K Sell
2,121
-1,213
-36% -$527K 0.09% 93
2024
Q4 		$1.38M Sell
3,334
-45
-1% -$19.7K 0.14% 79
2024
Q3 		$1.71M Sell
3,379
-29
-0.9% -$14.1K 0.19% 69
2024
Q2 		$1.66M Sell
3,408
-69
-2% -$34.6K 0.2% 64
2024
Q1 		$1.88M Sell
3,477
-371
-10% -$203K 0.24% 64
2023
Q4 		$2.14M Sell
3,848
-121
-3% -$56.8K 0.31% 56
2023
Q3 		$1.74M Sell
3,969
-252
-6% -$126K 0.28% 62
2023
Q2 		$2.12M Sell
4,221
-39
-0.9% -$18.7K 0.34% 55
2023
Q1 		$2.13M Sell
4,260
-87
-2% -$41.6K 0.37% 54
2022
Q4 		$1.77M Sell
4,347
-3
-0.1% -$1.17K 0.36% 65
2022
Q3 		$1.42M Sell
4,350
-270
-6% -$99.2K 0.31% 70
2022
Q2 		$1.62M Sell
4,620
-108
-2% -$44K 0.34% 61
2022
Q1 		$2.59M Sell
4,728
-119
-2% -$62.6K 0.47% 43
2021
Q4 		$3.19M Sell
4,847
-103
-2% -$64.7K 0.56% 36
2021
Q3 		$3.08M Sell
4,950
-104
-2% -$69.9K 0.61% 36
2021
Q2 		$3.19M Sell
5,054
-120
-2% -$66.3K 0.64% 33
2021
Q1 		$2.53M Sell
5,174
-80
-2% -$40.1K 0.58% 42
2020
Q4 		$2.78M Sell
5,254
-247
-4% -$111K 0.63% 32
2020
Q3 		$2.63M Sell
5,501
-25
-0.5% -$9.24K 0.72% 34
2020
Q2 		$2.07M Sell
5,526
-177
-3% -$51.2K 0.65% 38
2020
Q1 		$1.53M Sell
5,703
-253
-4% -$66K 0.59% 44
2019
Q4 		$1.7M Sell
5,956
-70
-1% -$18.4K 0.57% 50
2019
Q3 		$1.68M Sell
6,026
-209
-3% -$58.2K 0.63% 48
2019
Q2 		$1.74M Buy
6,235
+7
+0.1% +$1.73K 0.71% 47
2019
Q1 		$1.39M Hold
6,228
– – 0.61% 50
2018
Q4 		$1.16M Buy
+6,228
New +$1.28M 0.64% 47

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Means Investment Company's IDXX Position: Q1 2026 in Review

Means Investment Company reduced its Idexx Laboratories (IDXX) stake by 1.5% in Q1 2026, selling an estimated $17.3K and leaving 1,816 shares worth $1.02M. The position accounts for 0.09% of the portfolio, ranked #84.

Means Investment Company first reported a position in IDXX in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.19M in Q4 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Means Investment Company held 1,816 shares of Idexx Laboratories worth $1.02M as of Q1 2026.
  • Means Investment Company sold 27 Idexx Laboratories shares in Q1 2026, an estimated $17.3K.
  • Idexx Laboratories made up 0.09% of Means Investment Company's portfolio in Q1 2026, its #84 holding.
  • Means Investment Company first reported a position in Idexx Laboratories in Q4 2018 and has held it in 30 quarters since.
  • Means Investment Company's Idexx Laboratories position peaked at $3.19M in Q4 2021.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Means Investment Company's 13F filing for Q1 2026, filed 24 Apr 2026.